Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 6.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 895 citations

Medicine, Pharmacology, Pharmacotherapy +13

The outer membrane is an essential load-bearing element in Gram-negative bacteria

Enrique Rojas, Gabriel Billings, Pascal D. Odermatt et al. · Nature · 2018 · 637 citations · Full text

Life Sciences, Microbiology, Bacteriology +15

A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens

Meirong Song, Yuan Liu, Xiaoyong Huang et al. · Nature Microbiology · 2020 · 479 citations

Life Sciences, Infectious Diseases, Microbiology +14

Optimized arylomycins are a new class of Gram-negative antibiotics

Peter A. Smith, Michael F. T. Koehler, Hany S. Girgis et al. · Nature · 2018 · 357 citations

Life Sciences, Medicinal Chemistry, Microbiology +8